Robert Gould is the founder of Fulcrum Therapeutics. Fulcrum Therapeutics has raised $55M in total funding. Latest round: Series A.
Robert Gould is the founder and former CEO of Fulcrum Therapeutics, a biotechnology company focused on developing small-molecule therapies for genetic diseases. He led the company's launch with Series A financing from Third Rock Ventures. Gould currently serves as a Director at Fulcrum Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library